Showing results (671-680 of 798) with videos related to

Sort By:
Pageof 80
JAMA Internal Medicine|October 12, 2020
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysisMario Gaudino, Irbaz Hameed, Michael E Farkouh, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Development and validation of a model to categorize cardiovascular cause of death using health administrative dataSagar Patel, Wade Thompson, Atul Sivaswamy, et al.
Circulation|August 12, 2024
Mineralocorticoid Receptor Antagonism Prevents Aortic Plaque Progression and Reduces Left Ventricular Mass and Fibrosis in Patients With Type 2 Diabetes and Chronic Kidney Disease: The MAGMA TrialSanjay Rajagopalan, Mirela Dobre, Jean-Eudes Dazard, et al.
BMJ Open Diabetes Research & Care|August 8, 2025
Association between dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists and COVID-19 infection and adverse outcomes: a cohort studyWade Thompson, Bing Yu, Joan Porter, et al.
The Canadian Journal of Cardiology|March 4, 2019
Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern OntarioPatrick J Donio, Cassandra Freitas, Peter C Austin, et al.
Circulation. Cardiovascular Interventions|April 19, 2019
Clopidogrel PharmacogeneticsNaveen L Pereira, Charanjit S Rihal, Derek Y F So, et al.
Lancet (London, England)|August 25, 2004
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trialMichael E Farkouh, Howard Kirshner, Robert A Harrington, et al.
International Journal of Cardiology|August 31, 2018
Cost-effectiveness of on-pump and off-pump coronary artery bypass grafting for patients with coronary artery disease: Results from the MASS III trialThiago Luis Scudeler, Whady A Hueb, Michael E Farkouh, et al.
Journal of the American Heart Association|January 14, 2026
Cognitive Outcomes in Randomized Controlled Trials of Coronary Artery Bypass Graft Surgery From 2005 to 2025: A Systematic ReviewShantanu Srivatsa, Sajeevan Sujanthan, Sydni Paleczny, et al.
The Lancet. Healthy Longevity|September 2, 2023
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort studyCatarina Tristão-Pereira, Valentin Fuster, Belen Oliva, et al.
Pageof 80